In Minfos 8.3.2, a new Enquire button has been added to the Report Schedules window.

Select a report schedule and click Enquire to view the details of the report schedule including the recurrence pattern, email recipients and email details.

Furthermore, multi-select functionality is now available in the Report Schedules window, allowing you to efficiently make changes such as deletion or deactivation/activation to multiple report schedules at once. As with other windows in Minfos, use the [Shift] or [Ctrl] keys to select multiple report schedules.

Refer to Manage Scheduled Reports for further information.

This release introduces enhanced functionality for handling failed scheduled reports. Now, when scheduled reports fail to generate or send successfully, the scheduled report will be retried, and automatic notifications are sent to the recipients. After a certain amount of retries, the report schedule will be automatically deactivated.

This feature increases the reliability and transparency of scheduled reports.

How Failed Reports Are Managed:

• Once-Only Schedules:
  • If a once-only report fails, the schedule is automatically deactivated, preventing unnecessary retries.
  • Recipients receive an immediate notification informing them of the failure and deactivation.
• Daily Schedules:
  • For daily scheduled reports, the system automatically retries the report generation on the next business day, with a notification sent to recipients after each attempt.
  • If the report fails for four consecutive days, the schedule is deactivated, and recipients receive a detailed notification about the deactivation.

This feature ensures better management of scheduled reports, keeping recipients informed and minimizing repetitive failures.

Refer to Manage Scheduled Reports for further information.

The recently introduced report scheduling functionality is now available for the Sales Comparison report. Choose from various scheduling frequencies, including Once, Daily, Weekly, Monthly, and Yearly. The report will be generated after the End of Day process according to the specified schedule, and be conveniently emailed to specified addresses, providing you with the data you need whenever and wherever you need it.

The new Report on the Entire Range option allows you to dynamically set the category range for the Sales Comparison report, automatically including any new categories created within the specified range. 

Refer to Sales Comparison report for further details.

The Eighth Community Pharmacy Agreement announced that there will be a temporary freeze on indexation for Maximum Co-payment amounts for 2025, along with a reduction to the optional Co-payment discount. 

Concessional Patients 

From 2025 to 2029, the Maximum Allowable Discount for Concessional patients will be gradually reduced each year to offset the Co-payment freeze. In 2025, the Maximum Allowable Discount will be $0.80. 

General Patients 

For 2025 only, the Maximum Allowable Discount for General patients is $0.20. From 2026 onwards, indexation will resume, and the Allowable Discount will no longer apply to General patients. 

The January 2025 Dispense Update contains these fee changes  

The Maximum Allowable Discount values for both Concessional and General patients will be provided in the January 2025 Dispensary Updates. If the current Maximum Allowable Discount values in Minfos exceed these maximums (e.g., you have $1.00 set for both Concessional and General), the January Dispense Update will automatically adjust them to $0.80 and $0.20, respectively. 

If the Use max. govt discount checkbox is selected, these values will automatically update to $0.80 for Concessional and $0.20 for General. 

No changes will be made if the current discount values are already below the new Maximum Allowable Discount amounts. Refer to Set up Co-Payment Discount for further details.

From the 1st of January 2025, the Allowable discount (previously referred to as the Co-payment discount) will change from $1.00 to be $0.20 for General patients and $0.80 for Concessional patients.

The Department of Health and Aged Care has stated that the Allowable discount is a discount on the PBS patient co-payment itself i.e. the actual co-payment paid by a patient. 

Therefore, a General CTG patient's prescription can be discounted by up to the Allowable Concession discount amount of $0.80. Assuming the full Concession discount of $0.80 is applied, the General CTG patient will pay $6.90.

Example

A General CTG patient is supplied Cabergoline 500 microgram tablet – PBS Item Code 8114C, quantity = 8.
The Dispensed Price is $66.92
The General CTG patient co-payment is $7.70
The PBS Benefit is $59.22
The patient co-payment of $7.70 can be discounted by up to the Allowable Concession discount amount of $0.80.

Additional gender options have been added in the Loyalty Add/Edit Member windows. The expanded options include Other, Rather not say and Not specified. The default gender option is now Not specified. Keyboard shortcuts are available for these options, improving efficiency when adding or editing Loyalty members.

This change applies to both the Loyalty One and Generic Loyalty programs.

1. The correct Date will now be displayed for a patient’s Date Stamped Note.
2. Further improvements have been made to identify Authority Repatriation Scripts. When downloading an Authority Private item for a Repatriation patient, Minfos will populate the RxType as Authority.
3. Cancelling out of receiving an Owing Script when using an eScript will reset the Dispense Form. This is to ensure that the subsequent script is dispensed correctly.

1. The Invoice # in the Transfer Enquiry screen has been updated to reflect the Invoice No in the Tax Invoice.